The Plasmodium falciparum PPCS is a unique heteromeric complex with prokaryote-like activity and is a target of pantothenate analogs
Science Advances · 13.03.2026 · 12 (11)
DOI: 10.1126/sciadv.adx5265 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 13.03.2026. Verfasst von Xiangning Liu und 17 weiteren Autor:innen. Beteiligte Einrichtung: Research School of Biology, Australian National University, Canberra, ACT, Australia. Hauptthemen laut MEDLINE: Plasmodium falciparum, Pantothenic Acid, Peptide Synthases, Protozoan Proteins. Die Arbeit nennt 83 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Health and Medical Research Council, National Research Foundation of South Africa, Canadian institute of Health Research.
Abstract (Originalsprache)
Coenzyme A (CoA) is essential for the intraerythrocytic stage of Plasmodium falciparum . Phosphopantothenoylcysteine synthetase (PPCS) catalyzes the second of five steps of the CoA biosynthesis pathway. Most apicomplexan parasites express one PPCS, whereas two PPCSs are expressed in P. falciparum . Here, we demonstrate that the two P. falciparum PPCSs ( Pf PPCSs) associate into a single, functional PPCS heteromeric complex that, unlike any other eukaryotic PPCS reported to date, is unable to use adenosine 5′-triphosphate. We identify a prokaryote-like helical component of Pf PPCS as important for the nucleotide specificity and potentially holding the key for its stringency for cytidine 5′-triphosphate. Moreover, we show that the complex is the target of multiple antiplasmodial pantothenate analogs and interacts with other analogs that target different steps in CoA biosynthesis/utilization. Our study provides opportunities for designing inhibitors that exploit the unique features of the Pf PPCS complex while, at the same time, avoiding the human counterpart, paving the way for additional therapies to combat malaria.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Research School of Biology, Australian National University, Canberra, ACT, Australia.
- Department of Biochemistry, Stellenbosch University, Stellenbosch, South Africa.
- Department of Chemistry, McGill University, Montreal, Quebec, Canada.
- Australian Proteome Analysis Facility, Macquarie University, Sydney, NSW, Australia.
- Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, Australia.
ORCID-Profile: Xiangning Liu, Ruitao Jin, Riyad Domingo, Jinming Guan, Anton R Hamann, Gene Hart-Smith, Christina Spry, Anna E Sexton, Zoe Crooke, Darren J Creek, Karine Auclair, Ben Corry, Erick Strauss, Kevin J Saliba
Förderung
- National Health and Medical Research Council
- National Research Foundation of South Africa
- Canadian institute of Health Research
- Australian Government Research Training Program
- NRF and postdoctoral study support from the Oppenheimer Memorial Trust
Zitieren
APA
Liu, X., Jin, R., Domingo, R., Kotzé, T. J., Guan, J., Hamann, A. R., Chu, A., Hart-Smith, G., Spry, C., Sexton, A. E., Crooke, Z., Venkadeswaran, A., Yuan, X., Creek, D. J., Auclair, K., Corry, B., Strauss, E., & Saliba, K. J. (2026). The Plasmodium falciparum PPCS is a unique heteromeric complex with prokaryote-like activity and is a target of pantothenate analogs. Science Advances, 12(11). https://doi.org/10.1126/sciadv.adx5265
Vancouver
Liu X, Jin R, Domingo R, Kotzé TJ, Guan J, Hamann AR, et al. The Plasmodium falciparum PPCS is a unique heteromeric complex with prokaryote-like activity and is a target of pantothenate analogs. Science Advances. 2026;12(11). doi:10.1126/sciadv.adx5265
BibTeX
@article{Liu2026,
author = {Liu, Xiangning and Jin, Ruitao and Domingo, Riyad and Kotzé, Timothy J and Guan, Jinming and Hamann, Anton R and Chu, Annica and Hart-Smith, Gene and Spry, Christina and Sexton, Anna E and Crooke, Zoe and Venkadeswaran, Ajaay and Yuan, Xiaojun and Creek, Darren J and Auclair, Karine and Corry, Ben and Strauss, Erick and Saliba, Kevin J},
title = {The Plasmodium falciparum PPCS is a unique heteromeric complex with prokaryote-like activity and is a target of pantothenate analogs},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {11},
doi = {10.1126/sciadv.adx5265}
}
EUVIMED